SMI closes 0.14 percent higher as pharma shares offset yield pressure

The SMI closed at 13,808.42 points on October 7, 2026, at 5:31 p.m. CEST, up 0.14 percent from the previous close of 13,788.93. The index moved between 13,733.30 and 13,844.10 as higher oil prices and bond yields offset support from pharmaceutical stocks, according to finanzen.ch.

Pharmaceutical shares support the index

Roche gained 2.92 percent and Novartis rose 2.42 percent, helping the SMI outperform broader European markets. Swisscom advanced 2.87 percent, while Sandoz gained 1.40 percent. The defensive advance came as oil prices and bond yields increased amid renewed Middle East tensions and concerns over France's fiscal outlook, finanzen.ch reported.

Financial stocks weigh on the SMI

UBS fell 3.06 percent, while Holcim dropped 3.28 percent and ABB lost 3.27 percent. Partners Group declined 2.95 percent and Amrize slipped 2.66 percent. Ten SMI constituents finished lower, nine rose and one was unchanged, according to finanzen.ch.

Events for the next session

U.S. initial jobless claims are scheduled for October 8 at 8:30 a.m. ET, with economists expecting 200,000 claims against 197,000 previously. The U.S. Treasury is due to auction 30-year bonds at 1:00 p.m. ET, according to Investing.com. Those releases follow a session in which long-term yields and energy prices were central market influences.

More market reports and analysis on the SMI